Women Leading the Future of Immuno-Oncology

Women Leading the Future of Immuno-Oncology

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Women are at the forefront of IMMUNO-model COST Action, shaping the future of preclinical immuno-oncology models through leadership, collaboration, and groundbreaking research. Their work is essential in advancing immunotherapy and revolutionizing cancer treatments.

On February 11th, we celebrate the International Day of Women and Girls in Science, recognizing the incredible contributions of women in research and innovation. Their resilience and dedication drive progress, inspiring future generations to push scientific boundaries even further. 👩‍🔬

We extend our heartfelt thanks to all the IMMUNO-model female scientists who shared their photos for this tribute. While only some are featured in the video, many more outstanding women are part of this network, making invaluable contributions to the field. đź’™

🔬 Join us in honoring these brilliant scientists who are redefining the future of immuno-oncology!

Check video Women Leading the Future of Immuno-Oncology #science #immunomodel #cancerresearch – YouTube

Latest Updates

IMMUNO-model released Annual report for grant period 2, in which activities and achievements of IMMUNO-model are summarized.
Unraveling the contribution of post-transcriptional regulation in the cancer-immune cells cross-talk Jessica Dal ColAssistant Professor of Clinical PathologyDept. of Medicine, Surgery and Dentistry, University of Salerno, Italy View podcast here.
The Resistance, Chemotherapy, and Predictive Biomarkers (RCPB) group is seeking a highly qualified postdoctoral candidate to apply for an MSCA or AECC fellowship. Our research focuses on identifying mechanisms of resistance to...
IMMUNO-model Workshop: Harmonizing in vivo models of immunotherapy, past, present and future directions of WG 7-8 April 2025, Bergen, Norway Key dates Registration Travel expense reimbursement eligibility Speakers and abstract...
The third IMMUNO-model Annual Conference, “Modeling Immunotherapy for Cancer: Bridging Research to Clinical Application” will take place at University of Warsaw in Poland from 13-14th May 2025. The conference will...
The international conference “IMMUNO-model Second Annual Conference: From Pre-clinical Models to the Search for Biomarkers in Immuno-Oncology” was held in Bratislava from May 13th to 15th 2024. The conference was...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter